Are We Lacking Economic Evaluations in Gastric Cancer Treatment? Alyson L. MaharAbraham El-SedfyNatalie Coburn Commentary 06 September 2014 Pages: 83 - 87
Cost-Value Analysis of Health Interventions: Introduction and Update on Methods and Preference Data Erik Nord Current Opinion 09 December 2014 Pages: 89 - 95
A Primer on Marginal Effects—Part II: Health Services Research Applications E. OnukwughaJ. BergtoldR. Jain Practical Application 31 October 2014 Pages: 97 - 103
A Practical Guide to Value of Information Analysis Edward C. F. Wilson Practical Application 22 October 2014 Pages: 105 - 121
Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies Marieke KrolJocé PapenburgJob van Exel Systematic Review 15 October 2014 Pages: 123 - 135
Eribulin for the Treatment of Advanced or Metastatic Breast Cancer: A NICE Single Technology Appraisal Janette GreenhalghAdrian BagustSusan O’Reilly Review Article 12 September 2014 Pages: 137 - 148
Refitting of the UKPDS 68 Risk Equations to Contemporary Routine Clinical Practice Data in the UK P. McEwanH. BennettK. Bergenheim Original Research Article 26 October 2014 Pages: 149 - 161
Biological Therapies for the Treatment of Severe Psoriasis in Patients with Previous Exposure to Biological Therapy: A Cost-Effectiveness Analysis Laura M. SawyerDavid WonderlingCatherine H. Smith Original Research Article 20 December 2014 Pages: 163 - 177
Cost-Effectiveness Analysis of Prognostic Gene Expression Signature-Based Stratification of Early Breast Cancer Patients Patricia R. BlankMartin FilipitsMichael Gnant Original Research Article Open access 18 November 2014 Pages: 179 - 190